News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Toby Eyre/X
Jun 17, 2025, 09:52

Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Toby Eyre, CLL specialist at the Oxford University Hospitals, shared a post on X:

“Big CLL news!
Munir et al
OS and PFS adv for MRD driven I and V over ibrutinib in 1L CLL EHA 2025.
Congrats to all FLAIR trial group.
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia, New England Journal of Medicine”

Title: Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Journal: NEJM

Authors: Talha Munir, Sean Girvan, David A. Cairns, Adrian Bloor, David Allsup, Abraham M. Varghese, Satyen Gohil, Shankara Paneesha, Andrew Pettitt, Toby Eyre, Christopher P. Fox, Francesco Forconi, Constantine Balotis, Nicholas Pemberton, Oonagh Sheehy, John Gribben, Nagah Elmusharaf, Simona Gatto, Gavin Preston, Anna Schuh, Renata Walewska, Lelia Duley, Nichola Webster, Surita Dalal, Andrew Rawstron, Dena Howard, Anna Hockaday, Sharon Jackson, Natasha Greatorex, Sue Bell, David Stones, Julia M. Brown, Piers E.M. Patten, Peter Hillmen

Read the full article.

Residual Disease-Guided Therapy

Read “25 Posts Not to Miss from EHA 2025“.

Residual Disease-Guided Therapy

Abraham M. Varghese Adrian Bloor Andrew Pettitt Andrew Rawstron Anna Hockaday Anna Schuh cancer Christopher P. Fox chronic lymphocytic leukemia CLL Constantine Balotis David A. Cairns David Allsup David Stones Dena Howard FLAIR FLAIR trial Francesco Forconi Gavin Preston ibrutinib John Gribben Julia M. Brown Lelia Duley Nagah Elmusharaf Natasha Greatorex NEJM Nichola Webster Nicholas Pemberton OncoDaily Oncology Oonagh Sheehy Oxford University Hospitals Peter Hillmen Piers E.M. Patten Renata Walewska Satyen Gohil Sean Girvan Shankara Paneesha Sharon Jackson Simona Gatto Sue Bell Surita Dalal Talha Munir Toby Eyre
Special Coverage
Insight
Jun 17, 2025, 09:52
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Blog
Jun 17, 2025, 09:45
Are We Truly Addressing the Whole Person in Cancer Care? - SPCC
Science
Jun 17, 2025, 09:33
Rasha Aboelhassan: A New Ray of Hope for Stage III NSCLC with Neoadjuvant Immunotherapy
Career
Jun 17, 2025, 09:28
David Atallah: Honored to Receive 2025 Researcher Award and Outstanding Career from Salim Daccache and Richard Maroun
Science
Jun 17, 2025, 09:11
Myeloma Paper of the Day, June 17th, suggested by Robert Orlowski
Blog
Jun 17, 2025, 09:10
Join AACR in celebrating National Cancer Survivor Month
Blog
Jun 17, 2025, 09:05
Richard Scolyer Honored with Inaugural Award at Tour de Cure Snow Ball Event
Blog
Jun 17, 2025, 08:55
The Pillar 3 of the National Cancer Control Strategy - National Cancer Institute of Kenya
Blog
Jun 17, 2025, 08:51
Alice Lin Pomponio: Time to Grow Sustainably and Find Novel Ways to Advance Health Equity
Career
Jun 17, 2025, 08:42
Valerie Yang Has Been Appointed Senior Medical Oncologist at OncoCare Cancer Centre
Blog
Jun 17, 2025, 08:36
Anastasia Conti: The European Hematology Association Congress Was Amazing
Insight
Jun 17, 2025, 08:34
Katsuaki Maehara Shared an Article Published in Signal Transduction and Targeted Therapy on Molecular Pathology and Therapy of NSCLC